XML 17 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Public Offering
At-the-Market Offering
PREFERRED STOCK
COMMON STOCK
COMMON STOCK
Public Offering
COMMON STOCK
At-the-Market Offering
ADDITIONAL PAID-IN CAPITAL
ADDITIONAL PAID-IN CAPITAL
Public Offering
ADDITIONAL PAID-IN CAPITAL
At-the-Market Offering
ACCUMULATED DEFICIT
ACCUMULATED OTHER COMPREHENSIVE INCOME
Beginning balance (in shares) at Dec. 31, 2020         8,506,651              
Beginning balance at Dec. 31, 2020 $ 34,170       $ 1     $ 371,518     $ (337,406) $ 57
Increase (Decrease) in Shareholders' Equity                        
Net Loss (7,752)                   (7,752)  
Unrealized Loss on Available-for-Sale Investments (7)                     (7)
Foreign Currency Translation Adjustments 3                     3
Stock-based Compensation expense (in shares)         2,396              
Stock-based Compensation and modification expense (236)             (236)        
Ending balance (in shares) at Mar. 31, 2021         8,509,047              
Ending balance at Mar. 31, 2021 26,178       $ 1     371,282     (345,158) 53
Beginning balance (in shares) at Dec. 31, 2020         8,506,651              
Beginning balance at Dec. 31, 2020 34,170       $ 1     371,518     (337,406) 57
Increase (Decrease) in Shareholders' Equity                        
Net Loss (16,152)                      
Unrealized Loss on Available-for-Sale Investments (8)                      
Foreign Currency Translation Adjustments 3                      
Ending balance (in shares) at Jun. 30, 2021         8,528,307              
Ending balance at Jun. 30, 2021 18,203       $ 1     371,708     (353,558) 52
Beginning balance (in shares) at Mar. 31, 2021         8,509,047              
Beginning balance at Mar. 31, 2021 26,178       $ 1     371,282     (345,158) 53
Increase (Decrease) in Shareholders' Equity                        
Net Loss (8,400)                   (8,400)  
Unrealized Loss on Available-for-Sale Investments (1)                     (1)
Foreign Currency Translation Adjustments 0                      
Stock-based Compensation and modification expense 433             433        
Vesting of Restricted Stock Units Issued, net of taxes withheld (in shares)         19,260              
Vesting of Restricted Stock Units Issued, net of taxes withheld (7)             (7)        
Ending balance (in shares) at Jun. 30, 2021         8,528,307              
Ending balance at Jun. 30, 2021 $ 18,203       $ 1     371,708     (353,558) 52
Beginning balance (in shares) at Dec. 31, 2021 0     0                
Beginning balance (in shares) at Dec. 31, 2021 8,544,225       8,544,225              
Beginning balance at Dec. 31, 2021 $ 2,535       $ 1     372,562     (370,080) 52
Increase (Decrease) in Shareholders' Equity                        
Net Loss (7,162)                   (7,162)  
Foreign Currency Translation Adjustments (1)                     (1)
Stock-based Compensation and modification expense (179)             (179)        
Ending balance (in shares) at Mar. 31, 2022       0                
Ending balance (in shares) at Mar. 31, 2022         8,544,225              
Ending balance at Mar. 31, 2022 $ (4,807)       $ 1     372,383     (377,242) 51
Beginning balance (in shares) at Dec. 31, 2021 0     0                
Beginning balance (in shares) at Dec. 31, 2021 8,544,225       8,544,225              
Beginning balance at Dec. 31, 2021 $ 2,535       $ 1     372,562     (370,080) 52
Increase (Decrease) in Shareholders' Equity                        
Net Loss (12,128)                      
Unrealized Loss on Available-for-Sale Investments 0                      
Foreign Currency Translation Adjustments $ (3)                      
Ending balance (in shares) at Jun. 30, 2022 15,000     15,000                
Ending balance (in shares) at Jun. 30, 2022 9,407,296       9,407,296              
Ending balance at Jun. 30, 2022 $ 20,145       $ 1     402,304     (382,209) 49
Beginning balance (in shares) at Mar. 31, 2022       0                
Beginning balance (in shares) at Mar. 31, 2022         8,544,225              
Beginning balance at Mar. 31, 2022 (4,807)       $ 1     372,383     (377,242) 51
Increase (Decrease) in Shareholders' Equity                        
Net Loss (4,967)                   (4,967)  
Unrealized Loss on Available-for-Sale Investments 0                      
Foreign Currency Translation Adjustments (2)                     (2)
Issuance of stock, net of offering costs (in shares)       15,000   844,613 7,500          
Issuance of stock, net of offering costs (in dollars) 14,916 $ 14,893 $ 15         14,916 $ 14,893 $ 15    
Stock-based Compensation and modification expense $ 97             97        
Vesting of Restricted Stock Units Issued, net of taxes withheld (in shares)         10,958              
Ending balance (in shares) at Jun. 30, 2022 15,000     15,000                
Ending balance (in shares) at Jun. 30, 2022 9,407,296       9,407,296              
Ending balance at Jun. 30, 2022 $ 20,145       $ 1     $ 402,304     $ (382,209) $ 49